Jeffrey M. Cloutier

Jeffrey M. Cloutier, MD, PhD is an Assistant Professor of Pathology and Laboratory Medicine at the Geisel School of Medicine at Dartmouth College. His clinical practice and research focus on specialized areas of diagnostic pathology with particular expertise in bone and soft tissue tumors as well as skin pathology.

Dr. Cloutier received his educational training through an impressive academic path:

• B.A. from Middlebury College (2009)
• Ph.D. from University College London (2016)
• M.D. from The Johns Hopkins University School of Medicine (2017)
• Anatomic Pathology Residency at Stanford University Medical Center (2020)
• Dermatopathology Fellowship at Stanford University Medical Center (2021)
• Bone and Soft Tissue Pathology Fellowship at The University of Texas MD Anderson Cancer Center (2022)

Dr. Cloutier's research spans multiple specialized areas in pathology, with particular focus on the molecular and genetic underpinnings of challenging tumor entities. His work bridges diagnostic pathology with translational research, creating clinically relevant tools and insights for difficult diagnostic scenarios. He has developed particular expertise in the intersection of dermatopathology and soft tissue pathology, with numerous publications addressing diagnostic challenges in melanocytic lesions, sarcomas, and rare hybrid tumor entities. His dual fellowship training provides him with a unique perspective on cases that require expertise across multiple pathology subspecialties.

His recent publications demonstrate a strong emphasis on molecular diagnostics in challenging tumor entities, with particular focus on melanoma, sarcoma, and rare soft tissue tumors. Dr. Cloutier frequently collaborates with multidisciplinary teams to characterize novel molecular alterations in difficult diagnostic cases, often focusing on how these findings can be translated into practical diagnostic tools for pathologists. His work shows a consistent pattern of addressing diagnostic challenges through innovative molecular approaches while maintaining strong clinical relevance.